TABLE 4.

Secondary outcomes

	Intervention			Control
	Baseline	Intervention Follow-Up	Change	Baseline	Control Follow-Up	Change	Difference in Change
Mean reduction in diastolic blood pressure, mm Hg*	92	87	−5.1 ± 13.5	92	89	−3.0 ± 14.7	−2.1 mm Hg (95% CI: −4.5 to 0.3; p = 0.09)
Control rates of hypertension, %†	18.80	36.40	17.6	14.0	22.6	8.6	9 (p = 0.23)
Control rates of diabetes, %‡	6.20	34.30	28.1	14.5	29.0	14.5	13.6 (p = 0.66)
Statin use in participants with diabetes	3 (1.5)	7 (4.0)	2.5	0	1 (1.6)	1.6	0.9 (p = NS)
Statin use in participants with hypertension, who also smoke tobacco	1 (0.5)	0	−0.5	0	0	0	−0.5 (p = NS)
Aspirin use in participants with diabetes	1 (0.6)	4 (2.3)	1.7	0	1 (1.6)	1.6	0.1 (p = NS)
Participants who quit smoking at final follow-up		11.8 (26/220)			11.0 (19/173)		0.8 (p = 0.90)

Values are mean ± SD, n (%), or % (n/n), unless otherwise indicated.

^*Among participants with hypertension at baseline: intervention = 341, control = 186.

^†Defined as blood pressure <140/90 mm Hg: intervention = 341, control = 186.

^‡Defined as fasting blood sugar <126 mg/dl: intervention = 177, control = 61.

CI = confidence interval.